235 related articles for article (PubMed ID: 10408735)
1. The adverse effects of hormone replacement therapy.
Tavani A; La Vecchia C
Drugs Aging; 1999 May; 14(5):347-57. PubMed ID: 10408735
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
3. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
4. Menopause, hormone replacement therapy and cancer.
La Vecchia C; Brinton LA; McTiernan A
Maturitas; 2001 Aug; 39(2):97-115. PubMed ID: 11514109
[TBL] [Abstract][Full Text] [Related]
5. Evidence from randomised trials on the long-term effects of hormone replacement therapy.
Beral V; Banks E; Reeves G
Lancet; 2002 Sep; 360(9337):942-4. PubMed ID: 12354487
[TBL] [Abstract][Full Text] [Related]
6. Thromboembolism during hormone therapy in Japanese women.
Adachi T; Sakamoto S
Semin Thromb Hemost; 2005 Jun; 31(3):272-80. PubMed ID: 16052396
[TBL] [Abstract][Full Text] [Related]
7. Use of HRT and the subsequent risk of cancer.
Beral V; Banks E; Reeves G; Appleby P
J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the risk for venous thromboembolism among users of hormone replacement therapy.
Oger E; Scarabin PY
Drugs Aging; 1999 Jan; 14(1):55-61. PubMed ID: 10069408
[TBL] [Abstract][Full Text] [Related]
9. Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET).
Høibraaten E; Qvigstad E; Arnesen H; Larsen S; Wickstrøm E; Sandset PM
Thromb Haemost; 2000 Dec; 84(6):961-7. PubMed ID: 11154141
[TBL] [Abstract][Full Text] [Related]
10. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
Beral V; Bull D; Reeves G;
Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308
[TBL] [Abstract][Full Text] [Related]
11. Cancer issues.
Marsden J; Sturdee D
Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
[TBL] [Abstract][Full Text] [Related]
12. Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis.
Sare GM; Gray LJ; Bath PM
Eur Heart J; 2008 Aug; 29(16):2031-41. PubMed ID: 18599555
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy in prevention of morbidity and mortality in the older woman: part III: potential adverse effects of hormone replacement therapy.
Steffen KA; Carnes M
J Am Med Dir Assoc; 2000; 1(3):117-21. PubMed ID: 12818024
[TBL] [Abstract][Full Text] [Related]
14. Risk of hormone replacement therapy in stroke patients.
Damczyk MP; Gardner DM
J Clin Pharm Ther; 2000 Aug; 25(4):239-41. PubMed ID: 10971773
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy and cancer risk.
Mahavni V; Sood AK
Curr Opin Oncol; 2001 Sep; 13(5):384-9. PubMed ID: 11555717
[TBL] [Abstract][Full Text] [Related]
16. [Hormone replacement therapy and cancer of the breast. 1. Does replacement therapy increase the risk of cancer of the breast?].
Ayres de Campos D; Barros H; Martinez de Oliveira J
Acta Med Port; 1997 Oct; 10(10):697-703. PubMed ID: 9477595
[TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy and cardiovascular disease: increased risks of venous thromboembolism and stroke, and no protection from coronary heart disease.
Lowe GD
J Intern Med; 2004 Nov; 256(5):361-74. PubMed ID: 15485471
[TBL] [Abstract][Full Text] [Related]
18. Recent epidemiological studies of the association between hormone replacement therapy and venous thromboembolism. A review.
Castellsague J; Pérez Gutthann S; García Rodríguez LA
Drug Saf; 1998 Feb; 18(2):117-23. PubMed ID: 9512918
[TBL] [Abstract][Full Text] [Related]
19. HRT and cancer risk: separating fact from fiction.
Schneider HP
Maturitas; 1999 Nov; 33 Suppl 1():S65-72. PubMed ID: 10661617
[TBL] [Abstract][Full Text] [Related]
20. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.
Gomes MP; Deitcher SR
Arch Intern Med; 2004 Oct; 164(18):1965-76. PubMed ID: 15477430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
